Cover Image

OUTCOME OF INTRAVITREAL BEVACIZUMAB IN MYOPIC CHOROIDAL NEOVASCULARISATION

LALI L K

Abstract


AIM - To evaluate the efficacy of intravitreal bevacizumab in the treatment of high myopic choroidal   neovascularisation. METHOD - A retrospective study of seven eyes (six patients) with myopic choroidal neovascularisation (CNVM) from January 2013-January 2015. Best- corrected visual acuity (BCVA), fundus photography, fundus fluorescein angiography (FFA) and optical coherence tomography (OCT) were evaluated. Eyes were treated with monthly injections of intravitreal bevacizumab 2.5 mg0.1 ml for 3 months and  followed upto 6 months. BCVA and CNVM  area were compared before and after treatment.  RESULTS - Pre-treatment and post- treatment mean BCVA (decimal values) were 0.08 0.04 and 0.20.1 ,and the mean CNV area decreased from 1351 microns at baseline to 485.5 microns at 3 months. CONCLUSION - Intravitreal  bevacizumab seems to be an effective therapeutic procedure to treat extrafoveal and juxtafoveal CNVM in highly myopic eyes.

 


Full Text:

PDF

References


Wai-Man chan et al.Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularisation: six months results of a prospective pilot study. Ophthalmology, 2007;Dec.114 (12);2190-2196.

Arias L, Planas N, et al.Intarvitreal bevacizumab (Avastin) for choroidal neovascularisation secondary to pathological myopia :six month results.British Journal of Ophthalmology, 2008.Aug.92 (8);1035-1039.

Chan WM, Lai TY et al.Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularisation :one year results of a prospective pilot study. British Journal of Ophthalmology, 2009.Feb .93(2);150-154.

P-C Wu and Y-J Chen et al.Intravitreal injection of bevacizumab for myopic choroidal neovascularisation : one year follow-up. Eye (2009), 23;2042-2045.

Wang TY, Ferreira A,Hughes R.Epidemiology and disease burden of pathologic myopia and myopic choroidal neovascularisation :an evidence based systematic review.Am.J.Ophthalmol.2014 (157);9- 25.

Hayashi K et al.Characteristics of patients with a favourable natural course of myopic choroidal neovascularisation. Graefes Ach. Clin. Exp.Ophthalmol;2005, 243:13-19.

Wong TY et al.Myopic choroidal neovascularisation : current concepts and update on clinical management. Br.J.Ophthalmol, 2015, 99:289-296.

Lai TY et al.Long-term outcome of intravitreal anti- vascular endothelial growth factor therapy with bevacizumab or ranibizumab as primary treatment for subfoveal myopic choroidal neovascularisation. Eye (Lond) 2012; 26: 1004-11.

Leveziel N et al.Angiographic and optical coherence tomography characteristics of recent myopic choroidal neovascularisation. Am J Ophthalmol 2013; 155:913-19.

Yasushi Ikuno et al.Intravitreal Bevacizumab for myopic Choroidal Neovascularisation Attributable to Pathological Myopia: One -Year Results .Am J Ophthalmol 2009;vol 147; 94-100.

Yoshda.T, Ohno-matsui K,et al. Long term visual prognosis of Choroidal Neovascularisation in high myopia: a comparison between age groups.Ophthalmology,2002; 109:712-719.

Laud K,Spade RF., Freund KB. et al. Treatment of choroidal neovascularisation in pathologic myopia with intravitreal Bevacizumab.Retina .2006;26:960-963.

Sakaguchi H et al.Intravitreal injection of Bevacizumab for choroidal neovascularisation associated with pathological myopia.Br J Ophthalmol.2007:91:161-165.

Yamamoto I, Rogers H.A, Reichel E et al.Intravitreal bevacizumab as treatment for subfoveal choroidal neovascularisation secondary to pathologic myopia.Br J Ophthalmol 2007 91157-160.

Mandal S, Venkatesh P, Sampangi R.Intravitreal bevacizumab as a primary treatment for myopic choroidal neovascularisation.Eur J Ophthalmol.2007;17:620-26.

Ng DS, Kwok AK, Chan CW.Anti- vascular endothelial growth factor for myopic choroidal neovascularisation.Clin Experiment Ophthalmol.2012;40(1): e98-e110.


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

An Initiative of The Tamil Nadu Dr MGR Medical University